Enhanccd gene transfer and ccII death follo\Ving l'53 gene transfer using photochemical internalisation of glucosylatcd PEI-D A complexes, Gene Med, vol.6, issue.1, pp.884-894, 2004. ,
Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI), The Journal of Gene Medicine, vol.4, issue.3, pp.210-222, 1999. ,
DOI : 10.1042/bj1730723
Pholoehemical internalisation inereases Ihe cytolOxic cffecl of the immunotoxin MOC31-Gclonin, Inl J Cnneer, vol.87, pp.853-859, 2000. ,
B<lrberi-I-Ieyob M. el al: Oncoprotein expression of E6 and E7 does nol prevenl 5-11uorouracil (5FU) mediated G liS arrcsl and apoplosis in 5FU rcsistalll eareinoma ccli lines, Int J, vol.23, pp.81-87, 2003. ,
Adib 1\. el (II: III vÎlro dclivery 10 hepmo· cyles \Vith galaclosyled polyclhylcneimine, Bioconjugate Chelll, vol.8, pp.839-844, 1997. ,
el al: Transgene expression Îs increased by photochemically lllcdiated transduction of polycation-complexed adenoviruses. Gene Thel' II, pp.152-160, 2004. ,
Measurement of macromolecular diffusion coefficients in human tumors, Microvascular Research, vol.67, issue.3, pp.231-236, 2004. ,
DOI : 10.1016/j.mvr.2004.02.001
el al: Effects of adelloviral \Vild-typc"p53 gene transfer in p53-mlltaled Iymphoma cells, Cancer Gene Thel, vol.8, pp.430-439, 2001. ,
Barbcri-I-Icyob M. el lIl: G(I)/S bUI not G(O)lG( I)ccll fraction is rclaled to 5-11uorouracil cytoloxicity, Cyloll1WY, vol.48, pp.6-13, 2002. ,
EGFR overexpression was observed in PC3 cells (fig 2A) No PTEN expression was observed (fig 2B) Following gene transfer, pten gene was found to be restored (fig 2B) ,
AKT signaling Constitutive overexpression of phosphorylated-AKT (p-AKT) and consequent overexpression of AKT downstream signaling phosphoproteins, phosphorylated-GSK3 (p-GSK3 and phosphorylated-P70S6K (p-P70S6K) was observed in untransfected control cells as awaited in relation with pten-null phenotype (fig 3) Constitutive overexpression of ,
The EGF receptor family as targets for cancer therapy, Oncogene, vol.19, issue.56 ,
DOI : 10.1073/pnas.94.18.9562
The EGFR family and its ligands in human cancer, European Journal of Cancer, vol.37, pp.3-8, 2001. ,
DOI : 10.1016/S0959-8049(01)00230-1
Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer, Cancer Research, vol.66, issue.8, pp.3992-3995, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-0191
Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-379, 2008. ,
DOI : 10.1200/JCO.2007.12.5906
Additonal value of EGFR downstream signaling phosphoprotein expression to K-Ras mutation for response prediction to cetuximab in colorectal cancer, J Clin Oncol, vol.26, p.209, 2008. ,
BRAF andKRAS mutations in prostatic adenocarcinoma, International Journal of Cancer, vol.129, issue.8, pp.1858-1862, 2006. ,
DOI : 10.1111/j.1349-7006.2002.tb01318.x
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage, Clin Cancer Res, vol.59, pp.4291-4296, 1999. ,
The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate, Journal of Biological Chemistry, vol.317, issue.22, pp.13375-13378, 1998. ,
DOI : 10.1016/S0092-8674(00)80272-X
Autocrine Signaling through Ras Regulates Cell Survival Activity in Human Glioma Cells: Potential Cross-Talk between Ras and the Phosphatidylinositol 3-Kinase-Akt Pathway, Journal of Neuropathology & Experimental Neurology, vol.25, issue.11, pp.975-983, 2002. ,
DOI : 10.1017/S0317167100034272
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients, British Journal of Cancer, vol.24, issue.8, pp.1139-1184, 2007. ,
DOI : 10.1016/j.ctrv.2003.10.003
Sensitive detection of K-Ras mutations augments diagnosis of colorectal cancer metastases in the liver, Cancer Res, vol.59, pp.5169-5175, 1999. ,
Enhanced Cell Growth Inhibition following PTEN Nonviral Gene Transfer Using Polyethylenimine and Photochemical Internalization in Endometrial Cancer Cells, Technology in Cancer Research & Treatment, vol.58, issue.5, pp.459-465, 2004. ,
DOI : 10.1002/1097-0215(20000915)87:6<853::AID-IJC15>3.0.CO;2-0
Validation of phosphoprotein array assay for the determination of human epidermal growth factor receptors downstream signaling phosphoproteins in breast cancer, Eur J Cancer, vol.9, issue.96, 2008. ,
Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells, British Journal of Cancer, vol.83, issue.8, pp.1102-1109, 2000. ,
DOI : 10.1054/bjoc.2000.1400
Overexpression of PTEN Suppresses Growth and Induces Apoptosis by Inhibiting the Expression of Survivin in Bladder Cancer Cells, Tumor Biology, vol.24, issue.1, pp.9-15, 2006. ,
DOI : 10.1172/JCI200113345
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer, Journal of Cell Science, vol.121, issue.5, pp.664-674, 2008. ,
DOI : 10.1242/jcs.013029
Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells, Oncogene, vol.25, issue.4, pp.525-535, 2006. ,
DOI : 10.1038/sj.onc.1209075
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients, Cancer Cell, vol.6, issue.2, pp.117-127, 2004. ,
DOI : 10.1016/j.ccr.2004.06.022
Phosphoprotein Array in tumor biopsies for molecular diagnostis of PI3 Kinase and MAP Kinase signaling functionality, Mol. Cancer Ther, vol.6, p.3540, 2007. ,
Exploring human epidermal growth factor receptors downstream signaling by multiplex phosphoprotein determination in breast cancer ,
Signaling phosphoproteins in head and neck squamous cell carcinoma: relation with cellular sensitivity to cetuximab and interest of multiplex determination using Bio-Plex protein array, Proc Amer Assoc Cancer Res, vol.48, issue.185, 2007. ,
Adenoviralmediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells, Clin Cancer Res, vol.8, pp.1904-1918, 2002. ,
Gene therapy for prostate cancer: Current strategies and new cell-based approaches, The Prostate, vol.174, issue.5, pp.470-494, 2006. ,
DOI : 10.4049/jimmunol.174.6.3798
PhD Unité de Biologie des Tumeurs Centre Alexis Vautrin Avenue de Bourgogne 54511 Vandoeuvre-lès-Nancy cedex ,
The EGF receptor family as targets for cancer therapy, Oncogene, vol.19, issue.56 ,
DOI : 10.1073/pnas.94.18.9562
The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma, Journal of Immunotherapy, vol.19, issue.6, pp.419-446, 1996. ,
DOI : 10.1097/00002371-199611000-00006
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase, Clin Cancer Res, vol.6, pp.4885-92, 2000. ,
The EGFR family and its ligands in human cancer, European Journal of Cancer, vol.37, pp.3-8, 2001. ,
DOI : 10.1016/S0959-8049(01)00230-1
Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells, Anticancer Res, vol.19, pp.221-229, 1999. ,
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.21, issue.12, pp.2237-2283, 2003. ,
DOI : 10.1200/JCO.2003.10.038
Review of epidermal growth factor receptor biology, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.2, pp.21-27, 2004. ,
DOI : 10.1016/j.ijrobp.2003.11.041
Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7, Seminars in Cancer Biology, vol.13, issue.2, pp.169-78, 2003. ,
DOI : 10.1016/S1044-579X(02)00134-7
p53 enhances gefitinibinduced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer ,
EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer, Biochemical Pharmacology, vol.70, issue.11 ,
DOI : 10.1016/j.bcp.2005.09.007
p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas, Genes & Development, vol.16, issue.8, pp.984-93, 2002. ,
DOI : 10.1101/gad.973602
Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways, Life Sciences, vol.80, issue.23, pp.2137-2183, 2007. ,
DOI : 10.1016/j.lfs.2007.04.009
PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer, Science, vol.275, issue.5308, pp.1943-1950, 1997. ,
DOI : 10.1126/science.275.5308.1943
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage, Clin Cancer Res, vol.59, pp.4291-4297, 1999. ,
The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate, Journal of Biological Chemistry, vol.317, issue.22, pp.13375-13383, 1998. ,
DOI : 10.1016/S0092-8674(00)80272-X
The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene, Cancer Res, vol.58, pp.5667-72, 1998. ,
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN, Cell, vol.95, issue.1, pp.29-39, 1998. ,
DOI : 10.1016/S0092-8674(00)81780-8
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients, British Journal of Cancer, vol.24, issue.8, pp.1139-1184, 2007. ,
DOI : 10.1016/j.ctrv.2003.10.003
Resistance to gefitinib in PTEN-null HERoverexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3' -kinase/AKT pathway signalling, Cancer Res, vol.9, pp.4340-4346, 2003. ,
Sustained gene transfer and enhanced cell death following glucosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck carcinoma cells, International Journal of Oncology, vol.25, pp.1575-81, 2004. ,
DOI : 10.3892/ijo.25.6.1575
Enhanced Cell Growth Inhibition following PTEN Nonviral Gene Transfer Using Polyethylenimine and Photochemical Internalization in Endometrial Cancer Cells, Technology in Cancer Research & Treatment, vol.58, issue.5, pp.459-65, 2004. ,
DOI : 10.1002/1097-0215(20000915)87:6<853::AID-IJC15>3.0.CO;2-0
Eradication of p53-Mutated Head and Neck Squamous Cell Carcinoma Xenografts Using Nonviral p53 Gene Therapy and Photochemical Internalization, Molecular Therapy, vol.13, issue.6, pp.1156-62, 2006. ,
DOI : 10.1016/j.ymthe.2006.02.003
URL : https://hal.archives-ouvertes.fr/hal-00129944
Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells, The Prostate, vol.281, issue.8, pp.900-906, 2007. ,
DOI : 10.1002/pros.20568
Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells, British Journal of Cancer, vol.83, issue.8, pp.1102-1111, 2000. ,
DOI : 10.1054/bjoc.2000.1400
Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells, Oncogene, vol.25, issue.4, pp.525-560, 2006. ,
DOI : 10.1038/sj.onc.1209075
Overexpression of PTEN Suppresses Growth and Induces Apoptosis by Inhibiting the Expression of Survivin in Bladder Cancer Cells, Tumor Biology, vol.24, issue.1, pp.9-15, 2006. ,
DOI : 10.1172/JCI200113345
Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives, Cancer Gene Therapy, vol.8, issue.3, pp.203-213, 2001. ,
DOI : 10.1038/sj.cgt.7700289
Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes, The Journal of Gene Medicine, vol.6, issue.8, pp.884-94, 2004. ,
DOI : 10.1002/jgm.573
Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells, Clin Cancer Res, vol.8, pp.1904-1918, 2002. ,
3-Phosphoinositide-dependent Protein Kinase-1-mediated I??B Kinase ?? (IKKB) Phosphorylation Activates NF-??B Signaling, Journal of Biological Chemistry, vol.63, issue.49, pp.40965-73, 2005. ,
DOI : 10.1126/science.281.5385.2042
Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer, Cancer Research, vol.66, issue.8, pp.3992-3997, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-0191
Phosphoprotein Array in tumor biopsies for molecular diagnostis of PI3 Kinase and MAP Kinase signaling functionality, Mol. Cancer Ther, vol.6, p.3540, 2007. ,
Exploring human epidermal growth factor receptors downstream signaling by multiplex phosphoprotein determination in breast cancer, Proc Amer Assoc Cancer Res, vol.47, 2006. ,
Signaling phosphoproteins in head and neck squamous cell carcinoma: relation with cellular sensitivity to cetuximab and interest of multiplex determination using Bio-Plex protein array, Proc Amer Assoc Cancer Res, vol.48, 2007. ,
Adenoviral gene therapy in head and neck cancer, Drug News & Perspectives, vol.19, issue.6, pp.329-366, 2006. ,
DOI : 10.1358/dnp.2006.19.6.1015352
The Bcl-2 Protein Family: Arbiters of Cell Survival, Science, vol.281, issue.5381, pp.1322-1328, 1998. ,
DOI : 10.1126/science.281.5381.1322
p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts., Proceedings of the National Academy of Sciences, vol.92, issue.18, pp.92-8493, 1995. ,
DOI : 10.1073/pnas.92.18.8493
The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4, Biochemical Journal, vol.412, issue.2, pp.331-339, 2008. ,
DOI : 10.1042/BJ20071403
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis, The Journal of Gene Medicine, vol.70, issue.5, pp.657-63, 2005. ,
DOI : 10.1007/BF02789334
Cooperative Phosphorylation of the Tumor Suppressor Phosphatase and Tensin Homologue (PTEN) by Casein Kinases and Glycogen Synthase Kinase 3??, Journal of Biological Chemistry, vol.5, issue.42, pp.35195-202, 2005. ,
DOI : 10.1074/jbc.M504761200
PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family, Genes Dev, vol.14, issue.6, pp.704-722, 2000. ,
CDC2 is down-regulated by ionizing radiation in a p53-dependent manner, Cell Growth Differ, vol.8, issue.11, pp.1161-1170, 1997. ,
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas, Science, vol.244, issue.4901, pp.217-238, 1989. ,
DOI : 10.1126/science.2649981
mdm2 expression is induced by wild type p53 activity, Embo J, vol.12, issue.2, pp.461-469, 1993. ,
Crystal structure of human protein tyrosine phosphatase 1B, Science, vol.263, issue.5152, pp.1397-404, 1994. ,
DOI : 10.1126/science.8128219
Acetylation of p53 Activates Transcription through Recruitment of Coactivators/Histone Acetyltransferases, Molecular Cell, vol.8, issue.6, pp.1243-54, 2001. ,
DOI : 10.1016/S1097-2765(01)00414-2
Photochemical internalization (PCI)--a novel technology for release of macromolecules from endocytic vesicles, Oftalmologia, vol.56, issue.1, pp.67-71, 2003. ,
Photochemical Internalization, Cancer Res, vol.59, issue.6, pp.1180-1183, 1999. ,
DOI : 10.1201/b15582-42
URL : https://hal.archives-ouvertes.fr/hal-00129944
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors, Oncogene, vol.22, issue.18, pp.2812-2834, 2003. ,
DOI : 10.1038/ncb1101-973
Intracellular route and transcriptional competence of polyethylenimine???DNA complexes, Journal of Controlled Release, vol.82, issue.2-3, pp.441-54, 2002. ,
DOI : 10.1016/S0168-3659(02)00129-3
Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2., Proceedings of the National Academy of Sciences, vol.87, issue.12, pp.4766-70, 1990. ,
DOI : 10.1073/pnas.87.12.4766
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells, Science, vol.274, issue.5286, pp.373-379, 1996. ,
DOI : 10.1126/science.274.5286.373
Genetic analysis of colorectal cancer, Princess Takamatsu Symp, vol.20, pp.49-59, 1989. ,
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine., Proceedings of the National Academy of Sciences, vol.92, issue.16, pp.92-7297, 1995. ,
DOI : 10.1073/pnas.92.16.7297
An intact HDM2 RING-finger domain is required for nuclear exclusion of p53, Nature Cell Biology, vol.18, issue.9, pp.563-571, 2000. ,
DOI : 10.1093/emboj/18.1.22
Molecular staging of head and neck squamous carcinoma, Cancer and Metastasis Review, vol.120, issue.1, pp.3-10, 1996. ,
DOI : 10.1001/archotol.1994.01880330029006
Rescuing the function of mutant p53, Nature Reviews Cancer, vol.1, issue.1, pp.68-76, 2001. ,
DOI : 10.1038/35094077
Requirement for p53 and p21 to Sustain G2 Arrest After DNA Damage, Science, vol.282, issue.5393, pp.1497-501, 1998. ,
DOI : 10.1126/science.282.5393.1497
Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo, Oncogene, vol.20, issue.34, pp.4601-4613, 2001. ,
DOI : 10.1016/S0092-8674(00)80501-2
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound, Nature Medicine, vol.24, issue.3, pp.282-290, 2002. ,
DOI : 10.1093/nar/24.18.3560
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer, Cancer Res, vol.57, issue.22, pp.4997-5000, 1997. ,
Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor, Clin Cancer Res, vol.11, issue.1, pp.397-405, 2005. ,
Nuclear phosphoinositide-specific phospholipase C, phosphatidylinositol 4,5-bisphosphate and protein kinase C during rat spermatogenesis, Eur J Cell Biol, vol.71, issue.2, pp.154-64, 1996. ,
Epidermal growth factor, J Biol Chem, vol.265, issue.14, pp.7709-7721, 1990. ,
Mapping of the p53 and mdm-2 interaction domains., Molecular and Cellular Biology, vol.13, issue.7, pp.4107-4121, 1993. ,
DOI : 10.1128/MCB.13.7.4107
RAS/ERK modulates TGF??-regulated PTEN expression in human pancreatic adenocarcinoma cells, Carcinogenesis, vol.28, issue.11, pp.2321-2328, 2007. ,
DOI : 10.1093/carcin/bgm159
Regulation of p53 activity through lysine methylation, Nature, vol.50, issue.7015, pp.353-60, 2004. ,
DOI : 10.1107/S0907444994003112
Nuclear-Cytoplasmic Partitioning of Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Differentially Regulates the Cell Cycle and Apoptosis, Cancer Research, vol.65, issue.18, pp.8096-100, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-1888
Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Has Nuclear Localization Signal???Like Sequences for Nuclear Import Mediated by Major Vault Protein, Cancer Research, vol.65, issue.10, pp.4108-4124, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0124
The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation, Human Molecular Genetics, vol.59, issue.17, pp.2553-2562, 2006. ,
DOI : 10.1074/jbc.270.40.23589
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma., Journal of Clinical Oncology, vol.16, issue.6, pp.2221-2253, 1998. ,
DOI : 10.1200/JCO.1998.16.6.2221
A native 170,000 epidermal growth factor receptorkinase complex from shed plasma membrane vesicles, J Biol Chem, vol.257, issue.3, pp.1523-1554, 1982. ,
Regulates the Angiogenic Phenotype via PTEN Oxidation, Journal of Biological Chemistry, vol.318, issue.17, pp.16916-16940, 2005. ,
DOI : 10.1146/annurev.bi.64.070195.000525
The bcl2 family: regulators of the cellular life-or-death switch, Nature Reviews Cancer, vol.2, issue.9, pp.647-56, 2002. ,
DOI : 10.1038/nrc883
Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein., Proceedings of the National Academy of Sciences, vol.78, issue.1, pp.41-46, 1981. ,
DOI : 10.1073/pnas.78.1.41
Nuclear and nucleolar targeting sequences of c-erb-A, cmyb , N-myc, p53, HSP70, and HIV tat proteins, J Biol Chem, vol.264, issue.30, pp.18019-18042, 1989. ,
Membrane-binding and activation mechanism of PTEN, Proceedings of the National Academy of Sciences, vol.276, issue.35, pp.7491-7497, 2003. ,
DOI : 10.1074/jbc.R100007200
The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN, Carcinogenesis, vol.26, issue.10, pp.1793-803, 2005. ,
DOI : 10.1046/j.1365-2184.36.s.1.3.x
BAX and BAK mediate p53-independent suppression of tumorigenesis, Cancer Cell, vol.2, issue.3, pp.193-203, 2002. ,
DOI : 10.1016/S1535-6108(02)00126-5
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse., Proceedings of the National Academy of Sciences, vol.76, issue.5, pp.2420-2424, 1979. ,
DOI : 10.1073/pnas.76.5.2420
Impaired Fas Response and Autoimmunity in Pten+/ Mice, Science, vol.285, issue.5436, pp.2122-2127, 1999. ,
DOI : 10.1126/science.285.5436.2122
Pten is essential for embryonic development and tumour suppression, Nature Genetics, vol.225, issue.4, pp.348-55, 1998. ,
DOI : 10.1016/0076-6879(93)25057-9
[Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence?], Rev Laryngol Otol Rhinol (Bord), vol.120, issue.1, pp.5-12, 1999. ,
In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector, Cancer Gene Therapy, vol.15, issue.8, pp.708-722, 2002. ,
DOI : 10.1200/JCO.1997.15.3.1030
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours, Nature, vol.356, issue.6366, pp.215-236, 1992. ,
DOI : 10.1038/356215a0
Stimulation of PI 3-kinase signaling via inhibition of the tumor suppressor phosphatase, PTEN, Advances in Enzyme Regulation, vol.47, issue.1, pp.184-94, 2007. ,
DOI : 10.1016/j.advenzreg.2006.12.018
The Tumor Suppressor PTEN Is Necessary for Human Sprouty 2-mediated Inhibition of Cell Proliferation, Journal of Biological Chemistry, vol.12, issue.8, pp.4816-4838, 2006. ,
DOI : 10.1016/S0960-9822(00)00417-6
Analysis of PTEN and the 10q23 region in primary prostate carcinomas, Oncogene, vol.16, issue.13, pp.1743-1751, 1998. ,
DOI : 10.1038/sj.onc.1200205
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure., Proceedings of the National Academy of Sciences, vol.84, issue.21, pp.7413-7420, 1987. ,
DOI : 10.1073/pnas.84.21.7413
Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase, Journal of Biological Chemistry, vol.217, issue.39, pp.41189-96, 2004. ,
DOI : 10.1074/jbc.M303083200
ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo, Gene Therapy, vol.4, issue.10, pp.1100-1106, 1997. ,
DOI : 10.1038/sj.gt.3300503
and Survival in Patients With Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.23, issue.9, pp.1921-1927, 2005. ,
DOI : 10.1200/JCO.2005.08.127
Presence of a potent transcription activating sequence in the p53 protein, Science, vol.249, issue.4972, pp.1046-1055, 1990. ,
DOI : 10.1126/science.2144363
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients, British Journal of Cancer, vol.24, issue.8, pp.1139-1184, 2007. ,
DOI : 10.1016/j.ctrv.2003.10.003
Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6, Molecular and Cellular Biology, vol.18, issue.12, pp.7288-93, 1998. ,
DOI : 10.1128/MCB.18.12.7288
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.21, issue.12, pp.2237-2283, 2003. ,
DOI : 10.1200/JCO.2003.10.038
Phase I???II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas, Gene Therapy, vol.89, issue.5, pp.437-482, 2005. ,
DOI : 10.1093/jnci/89.15.1138
Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1, Journal of Biological Chemistry, vol.269, issue.19, pp.13176-80, 1999. ,
DOI : 10.1093/nar/21.4.1047
The MDM2 RING-finger domain is required to promote p53 nuclear export, Nature Cell Biology, vol.13, issue.9, pp.569-73, 2000. ,
DOI : 10.1128/MCB.13.9.5186
Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid Tumors, The American Journal of Pathology, vol.156, issue.5, pp.1693-700, 2000. ,
DOI : 10.1016/S0002-9440(10)65040-7
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency, Gene Therapy, vol.68, issue.8, pp.1380-1388, 1999. ,
DOI : 10.1073/pnas.80.12.3734
The molecular genetics of retinoblastoma, Cancer Surv, vol.9, issue.3, pp.529-54, 1990. ,
MOLECULAR BIOLOGY: Getting p53 Out of the Nucleus, Science, vol.292, issue.5523, pp.1851-1853, 2001. ,
DOI : 10.1126/science.1062238
p53 and Metabolism: Inside the TIGAR, Cell, vol.126, issue.1, pp.30-32, 2006. ,
DOI : 10.1016/j.cell.2006.06.032
Alterations of the MMAC1/PTEN gene in lymphoid malignancies, Blood, vol.91, issue.11, pp.4388-90, 1998. ,
Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor???mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways, The Journal of Cell Biology, vol.17, issue.5, pp.1375-83, 1998. ,
DOI : 10.1016/0955-0674(95)80110-3
Dérégulation moléculaire et cancer: prolifération, survie et inhibition de l'apoptose, the international ImMunoGeneTics information system*, 2002. ,
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma, Cancer Res, vol.57, issue.17, pp.3660-3663, 1997. ,
Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation, Nucleic Acids Research, vol.24, issue.6, pp.1119-1145, 1996. ,
DOI : 10.1093/nar/24.6.1119
Rosiglitazone suppresses human lung carcinoma cell growth through PPAR??-dependent and PPAR??-independent signal pathways, Molecular Cancer Therapeutics, vol.5, issue.2, pp.430-437, 2006. ,
DOI : 10.1158/1535-7163.MCT-05-0347
Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells, J Virol, vol.37, issue.2, pp.564-73, 1981. ,
Importance of p53 for cancer onset and therapy, Anti-Cancer Drugs, vol.17, issue.7, pp.725-757, 2006. ,
DOI : 10.1097/01.cad.0000217422.52208.fa
Mdm2 promotes the rapid degradation of p53, Nature, vol.387, issue.6630, pp.296-305, 1997. ,
DOI : 10.1038/387296a0
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents, Nature Medicine, vol.55, issue.6, pp.639-684, 1997. ,
DOI : 10.1101/gad.7.4.546
Review of epidermal growth factor receptor biology, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.2, pp.21-27, 2004. ,
DOI : 10.1016/j.ijrobp.2003.11.041
IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer, Semin Oncol, vol.295, pp.18-30, 2002. ,
c-Jun promotes cellular survival by suppression of PTEN, Cell Death and Differentiation, vol.280, issue.2, pp.218-247, 2007. ,
DOI : 10.1016/S1383-5718(01)00179-6
The mechanism of action of the tumour suppressor gene pten, Biomedical Papers, vol.147, issue.1, pp.19-25, 2003. ,
DOI : 10.5507/bp.2003.003
Photochemical internalisation in drug and gene delivery, Advanced Drug Delivery Reviews, vol.56, issue.1, pp.95-115, 2004. ,
DOI : 10.1016/j.addr.2003.08.016
p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers, Carcinogenesis, vol.15, issue.1, pp.1-3, 1994. ,
DOI : 10.1093/carcin/15.1.1
p53 mutations in human cancers, Science, vol.253, issue.5015, pp.49-53, 1991. ,
DOI : 10.1126/science.1905840
p53 regulates maternal reproduction through LIF, Nature, vol.10, issue.7170, pp.721-725, 2007. ,
DOI : 10.1111/j.1600-0897.1998.tb00345.x
EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer, Biochemical Pharmacology, vol.70, issue.11, pp.1568-78, 2005. ,
DOI : 10.1016/j.bcp.2005.09.007
Small molecule RITA binds to p53, blocks p53???HDM-2 interaction and activates p53 function in tumors, Nature Medicine, vol.98, issue.12, pp.1321-1329, 2004. ,
DOI : 10.1073/pnas.98.3.1218
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways, Cancer Cell, vol.4, issue.4, pp.321-329, 2003. ,
DOI : 10.1016/S1535-6108(03)00244-7
Commentary on "Participation of p53 Protein in the Cellular Response to DNA Damage", Cancer Research, vol.76, issue.13, pp.6304-6315, 1991. ,
DOI : 10.1158/0008-5472.CAN-16-1560
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics, Nature Medicine, vol.9, issue.1, pp.33-40, 2001. ,
DOI : 10.1016/S0958-1669(98)80032-3
Bcl-2-family proteins: the role of the BH3 domain in apoptosis, Trends in Cell Biology, vol.8, issue.8, pp.324-354, 1998. ,
DOI : 10.1016/S0962-8924(98)01321-X
Polyethylenimine-mediated gene delivery: a mechanistic study, The Journal of Gene Medicine, vol.7, issue.2, pp.135-179, 2001. ,
DOI : 10.1021/bc9600630
Concomitant Inhibition of MDM2 and Bcl-2 Protein Function Synergistically Induce Mitochondrial Apoptosis in AML, Cell Cycle, vol.5, issue.23, pp.2778-86, 2006. ,
DOI : 10.4161/cc.5.23.3520
Regulation of p53 stability by Mdm2, Nature, vol.387, issue.6630, pp.299-303, 1997. ,
DOI : 10.1038/387299a0
Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors, Proceedings of the National Academy of Sciences, vol.332, issue.6165, pp.16419-16443, 2004. ,
DOI : 10.1038/332644a0
Phosphorylation of p53 Serine 15 Increases Interaction with CBP, Journal of Biological Chemistry, vol.5, issue.49, pp.33048-53, 1998. ,
DOI : 10.1038/sj.onc.1201244
T antigen is bound to a host protein in SY40-transformed cells, Nature, vol.29, issue.5701, pp.261-264, 1979. ,
DOI : 10.1016/0042-6822(78)90171-X
Crystal Structure of the PTEN Tumor Suppressor, Cell, vol.99, issue.3, pp.323-357, 1999. ,
DOI : 10.1016/S0092-8674(00)81663-3
Redox regulation of PI 3-kinase signalling via inactivation of PTEN, The EMBO Journal, vol.22, issue.20, pp.5501-5511, 2003. ,
DOI : 10.1093/emboj/cdg513
TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta, Cancer Res, vol.57, issue.11, pp.2124-2133, 1997. ,
PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer, Science, vol.275, issue.5308, pp.1943-1950, 1997. ,
DOI : 10.1126/science.275.5308.1943
Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells, Oncogene, vol.25, issue.4, pp.525-560, 2006. ,
DOI : 10.1038/sj.onc.1209075
Regulation of PTEN by Rho small GTPases, Nature Cell Biology, vol.4, issue.4, pp.399-404, 2005. ,
DOI : 10.1038/ni892
Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-383, 2008. ,
DOI : 10.1200/JCO.2007.12.5906
URL : https://hal.archives-ouvertes.fr/hal-00363737
The SV40 a gene product is required for the production of a 54,000 MW cellular tumor antigen, Virology, vol.98, issue.2, pp.308-326, 1979. ,
DOI : 10.1016/0042-6822(79)90554-3
Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation, Molecular and Cellular Biology, vol.25, issue.14, pp.6211-6235, 2005. ,
DOI : 10.1128/MCB.25.14.6211-6224.2005
Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype., Journal of Medical Genetics, vol.35, issue.11, pp.886-895, 1998. ,
DOI : 10.1136/jmg.35.11.886
Human TAFII31 protein is a transcriptional coactivator of the p53 protein., Proceedings of the National Academy of Sciences, vol.92, issue.11, pp.5154-5162, 1995. ,
DOI : 10.1073/pnas.92.11.5154
The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate, Journal of Biological Chemistry, vol.317, issue.22, pp.13375-13383, 1998. ,
DOI : 10.1016/S0092-8674(00)80272-X
Mesangial Cell Hypertrophy by High Glucose Is Mediated by Downregulation of the Tumor Suppressor PTEN, Diabetes, vol.55, issue.7, pp.2115-2140, 2006. ,
DOI : 10.2337/db05-1326
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, vol.250, issue.4985, pp.1233-1241, 1990. ,
DOI : 10.1126/science.1978757
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation, Human Molecular Genetics, vol.7, issue.3, pp.507-522, 1998. ,
DOI : 10.1093/hmg/7.3.507
Germline mutations in PTEN are present in Bannayan-Zonana syndrome, Nature Genetics, vol.112, issue.4, pp.333-337, 1997. ,
DOI : 10.1001/jama.276.19.1575
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors, Cell, vol.127, issue.7, pp.1323-1357, 2006. ,
DOI : 10.1016/j.cell.2006.12.007
Twenty years of p53 research: structural and functional aspects of the p53 protein, Oncogene, vol.18, issue.53, pp.7621-7657, 1999. ,
DOI : 10.1038/372773a0
Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus., Journal of Histochemistry & Cytochemistry, vol.43, issue.2, pp.181-91, 1995. ,
DOI : 10.1177/43.2.7822774
mutation for response prediction to cetuximab in colorectal cancer (CRC), Journal of Clinical Oncology, vol.26, issue.15_suppl, p.209, 2008. ,
DOI : 10.1200/jco.2008.26.15_suppl.4126
Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives, Cancer Gene Therapy, vol.8, issue.3, pp.203-213, 2001. ,
DOI : 10.1038/sj.cgt.7700289
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, issue.2, pp.293-302, 1995. ,
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell, vol.69, issue.7, pp.1237-1282, 1992. ,
DOI : 10.1016/0092-8674(92)90644-R
[Targeting of membrane receptor tyrosine kinases: is there resistance in the HER, Bull Cancer, vol.91, issue.9, pp.685-94, 2004. ,
PDK1, the master regulator of AGC kinase signal transduction, Seminars in Cell & Developmental Biology, vol.15, issue.2, pp.161-70, 2004. ,
DOI : 10.1016/j.semcdb.2003.12.022
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study, The Lancet Oncology, vol.6, issue.5, pp.279-86, 2005. ,
DOI : 10.1016/S1470-2045(05)70102-9
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs, The Journal of Experimental Medicine, vol.54, issue.11, pp.2033-2078, 1998. ,
DOI : 10.1038/ng1097-141
Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin???s lymphoma, Leukemia, vol.12, issue.8, pp.1277-80, 1998. ,
DOI : 10.1038/sj.leu.2401099
PUMA, a Novel Proapoptotic Gene, Is Induced by p53, Molecular Cell, vol.7, issue.3, pp.683-94, 2001. ,
DOI : 10.1016/S1097-2765(01)00214-3
PTEN mutations are common in sporadic microsatellite stable colorectal cancer, Oncogene, vol.23, issue.2, pp.617-645, 2004. ,
DOI : 10.1016/S0002-9440(10)64200-9
Eradication of p53-Mutated Head and Neck Squamous Cell Carcinoma Xenografts Using Nonviral p53 Gene Therapy and Photochemical Internalization, Molecular Therapy, vol.13, issue.6, pp.1156-62, 2006. ,
DOI : 10.1016/j.ymthe.2006.02.003
URL : https://hal.archives-ouvertes.fr/hal-00129944
A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients, Cancer Gene Therapy, vol.72, issue.11, pp.885-93, 2007. ,
DOI : 10.1016/j.ymeth.2005.11.005
APOPTOSIS: Life and Death Decisions, Science, vol.299, issue.5604, pp.214-219, 2003. ,
DOI : 10.1126/science.1081274
Mutations in the p53 gene occur in diverse human tumour types, Nature, vol.342, issue.6250, pp.705-713, 1989. ,
DOI : 10.1038/342705a0
The importance of p53 location: nuclear or cytoplasmic zip code?, Drug Resist Updat, vol.6, issue.6, pp.313-335, 2003. ,
Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer, Clinical Cancer Research, vol.11, issue.18, pp.6650-6656, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0738
Regulation of PTEN Phosphorylation and Stability by a Tumor Suppressor Candidate Protein, Journal of Biological Chemistry, vol.169, issue.44, pp.45300-45303, 2004. ,
DOI : 10.1126/science.1092089
Critical Role of PICT-1, a Tumor Suppressor Candidate, in Phosphatidylinositol 3,4,5-Trisphosphate Signals and Tumorigenic Transformation, Molecular Biology of the Cell, vol.17, issue.11, pp.4888-95, 2006. ,
DOI : 10.1091/mbc.E06-04-0301
Casein kinase I?? down-regulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells, Life Sciences, vol.78, issue.14, pp.1624-1633, 2006. ,
DOI : 10.1016/j.lfs.2005.07.041
PTEN expression elicited byEGR-1 transcription factor in calyculin A-induced apoptotic cells, Journal of Cellular Biochemistry, vol.14, issue.1, pp.117-142, 2005. ,
DOI : 10.1038/sj.gt.3300598
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53, Nature, vol.362, issue.6423, pp.857-60, 1993. ,
DOI : 10.1038/362857a0
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells., Molecular and Cellular Biology, vol.1, issue.2, pp.101-111, 1981. ,
DOI : 10.1128/MCB.1.2.101
Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation, Embo J, vol.13, issue.15, pp.3496-504, 1994. ,
The p110?? isoform of PI 3-kinase negatively controls RhoA and PTEN, The EMBO Journal, vol.19, issue.13, pp.3050-61, 2007. ,
DOI : 10.4049/jimmunol.170.5.2647
Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies, Toxicology Letters, vol.150, issue.1, pp.43-56, 2004. ,
DOI : 10.1016/j.toxlet.2003.06.001
Tumor suppressor and anti-inflammatory actions of PPAR?? agonists are mediated via upregulation of PTEN, Current Biology, vol.11, issue.10, pp.764-772, 2001. ,
DOI : 10.1016/S0960-9822(01)00225-1
Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast, The American Journal of Pathology, vol.155, issue.4, pp.1253-60, 1999. ,
DOI : 10.1016/S0002-9440(10)65227-3
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients, Annals of Oncology, vol.13, issue.44, 2008. ,
DOI : 10.3748/wjg.v13.i44.5877
The mdm-2 gene is induced in response to UV light in a p53-dependent manner., Proceedings of the National Academy of Sciences, vol.90, issue.24, pp.90-11623, 1993. ,
DOI : 10.1073/pnas.90.24.11623
Response prediction to cetuximab-based therapy: The role of EGFR copy number by fluorescence in situ hybridization and downstream effectors gene mutations, Gastrointestinal Cancers Symposium abstract 400 ,
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, Proceedings of the National Academy of Sciences, vol.8, issue.21, pp.1563-1571, 1999. ,
DOI : 10.1016/S0960-9822(07)00488-5
Evaluation of Different Photosensitizers for Use in Photochemical Gene Transfection??, Photochemistry and Photobiology, vol.10, issue.4, pp.388-95, 2001. ,
DOI : 10.1562/0031-8655(2000)072<0554:UEEOAR>2.0.CO;2
The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma, Journal of Immunotherapy, vol.19, issue.6, pp.419-446, 1996. ,
DOI : 10.1097/00002371-199611000-00006
Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo, Mol Med, vol.11, issue.112, pp.59-63, 2005. ,
Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study, BMC Cancer, vol.112, issue.3, p.234, 2008. ,
DOI : 10.1002/ijc.20447
Characterization of the p53-rescue drug CP-31398 in vitro and in living cells, Oncogene, vol.21, issue.14, pp.2119-2148, 2002. ,
DOI : 10.1073/pnas.96.15.8438
Viral vectors for gene therapy, Trends in Biotechnology, vol.16, issue.1, pp.35-40, 1998. ,
DOI : 10.1016/S0167-7799(97)01137-2
In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma, Proceedings of the National Academy of Sciences, vol.56, issue.9, pp.95-9418, 1998. ,
DOI : 10.1002/gcc.2870120404
EGFR gene status, K-Ras mutation and PTEN expression predict cetuximab response in metastatic colorectal cancer, Gastrointestinal Cancers Symposium: Abstract 427 ,
DNA damage activates p53 through a phosphorylation-acetylation cascade, Genes & Development, vol.12, issue.18, pp.2831-2872, 1998. ,
DOI : 10.1101/gad.12.18.2831
PTEN gene alterations in lymphoid neoplasms, Blood, vol.92, issue.9, pp.3410-3415, 1998. ,
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex, Science, vol.307, issue.5712, pp.1098-101, 2005. ,
DOI : 10.1126/science.1106148
Photochemical Internalisation: A Novel Drug Delivery System, Tumor Biology, vol.23, issue.2, pp.103-115, 2002. ,
DOI : 10.1159/000059713
The Major Target of the Endogenously Generated Reactive Oxygen Species in Response to Insulin Stimulation Is Phosphatase and Tensin Homolog and Not Phosphoinositide-3 Kinase (PI-3 Kinase) in the PI-3 Kinase/Akt Pathway, Molecular Biology of the Cell, vol.16, issue.1, pp.348-57, 2005. ,
DOI : 10.1091/mbc.E04-05-0369
Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3' -kinase/Akt pathway signaling, Clin Cancer Res, vol.9, issue.12, pp.4340-4346, 2003. ,
Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling, Journal of Biological Chemistry, vol.7, issue.12, pp.7727-7763, 2006. ,
DOI : 10.1074/jbc.272.50.31400
Tumor suppressor p53: regulation and function, Frontiers in Bioscience, vol.5, issue.1, pp.424-461, 2000. ,
DOI : 10.2741/Somasund
Assessing TP53 status in human tumours to evaluate clinical outcome, Nature Reviews Cancer, vol.91, issue.3, pp.233-273, 2001. ,
DOI : 10.1111/j.1349-7006.2000.tb00931.x
Structural aspects of the p53 protein in relation to gene evolution, Oncogene, vol.5, issue.7, pp.945-52, 1990. ,
p53 mutation heterogeneity in cancer, Biochemical and Biophysical Research Communications, vol.331, issue.3, pp.834-876, 2005. ,
DOI : 10.1016/j.bbrc.2005.03.190
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li???Fraumeni syndrome, Nature, vol.348, issue.6303, pp.747-756, 1990. ,
DOI : 10.1038/348747a0
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN, Cell, vol.95, issue.1, pp.29-39, 1998. ,
DOI : 10.1016/S0092-8674(00)81780-8
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nature Genetics, vol.263, issue.4, pp.356-62, 1997. ,
DOI : 10.1038/ng0696-241
Integration of the pRB and p53 cell cycle control pathways, Journal of Neuro-Oncology, vol.51, issue.3, pp.183-204, 2001. ,
DOI : 10.1023/A:1010615822317
Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 ?? and the complex with tungstate, Nature, vol.370, issue.6490, pp.571-576, 1994. ,
DOI : 10.1038/370571a0
PTEN and phosphatidylinositol 3' -kinase inhibitors upregulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment, Cancer Res, vol.63, issue.13, pp.3585-92, 2003. ,
Vinculin Controls PTEN Protein Level by Maintaining the Interaction of the Adherens Junction Protein ??-Catenin with the Scaffolding Protein MAGI-2, Journal of Biological Chemistry, vol.4, issue.7, pp.5676-81, 2005. ,
DOI : 10.1006/mcne.2002.1115
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway, Proceedings of the National Academy of Sciences, vol.95, issue.1, pp.96-6199, 1999. ,
DOI : 10.1016/S0092-8674(00)81780-8
PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling, The EMBO Journal, vol.94, issue.4, pp.910-930, 2006. ,
DOI : 10.1042/bj2980517
3-Phosphoinositide-dependent Protein Kinase-1-mediated I??B Kinase ?? (IKKB) Phosphorylation Activates NF-??B Signaling, Journal of Biological Chemistry, vol.63, issue.49, pp.40965-73, 2005. ,
DOI : 10.1126/science.281.5385.2042
The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus, Journal of Biological Chemistry, vol.37, issue.2, pp.993-1001, 2001. ,
DOI : 10.1016/S0959-8049(00)00366-X
Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression, Cell, vol.128, issue.1, pp.141-56, 2007. ,
DOI : 10.1016/j.cell.2006.11.040
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha, J Immunol, vol.160, issue.3, pp.1139-1186, 1998. ,
Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases, Journal of Biological Chemistry, vol.61, issue.32, pp.28936-28979, 2005. ,
DOI : 10.1016/S1535-6108(03)00331-3
Molecular Determinants of Cetuximab Efficacy, Journal of Clinical Oncology, vol.23, issue.15, pp.3536-3580, 2005. ,
DOI : 10.1200/JCO.2005.09.100
Adenoviral gene therapy in head and neck cancer, Drug News & Perspectives, vol.19, issue.6, pp.329-366, 2006. ,
DOI : 10.1358/dnp.2006.19.6.1015352
Regulation of PTEN Function as a PIP3 Gatekeeper Through Membrane Interaction, Cell Cycle, vol.5, issue.14, pp.1523-1530, 2006. ,
DOI : 10.4161/cc.5.14.3005
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function, Molecular and Cellular Biology, vol.20, issue.14, pp.5010-5018, 2000. ,
DOI : 10.1128/MCB.20.14.5010-5018.2000
Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses, Journal of Neuro-Oncology, vol.65, issue.3, pp.237-283, 2003. ,
DOI : 10.1023/B:NEON.0000003653.45635.32
The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression, The EMBO Journal, vol.17, issue.16, pp.4668-79, 1998. ,
DOI : 10.1093/emboj/17.16.4668
Restoration of p53 function leads to tumour regression in vivo, Nature, vol.119, issue.7128, pp.661-666, 2007. ,
DOI : 10.1016/j.cell.2004.11.004
Plasma Phytoestrogens and Subsequent Breast Cancer Risk, Journal of Clinical Oncology, vol.25, issue.6, pp.648-55, 2007. ,
DOI : 10.1200/JCO.2006.06.0244
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling, Nature Cell Biology, vol.17, issue.12, pp.1124-1132, 2001. ,
DOI : 10.1083/jcb.17.2.299
Switching from life to death: The Miz-ing link between Myc and p53, Cancer Cell, vol.2, issue.5, pp.351-353, 2002. ,
DOI : 10.1016/S1535-6108(02)00186-1
Protean PTEN: Form and Function, The American Journal of Human Genetics, vol.70, issue.4, pp.829-873, 2002. ,
DOI : 10.1086/340026
Phytoestrogen exposure elevates PTEN levels, Human Molecular Genetics, vol.14, issue.11, pp.1457-63, 2005. ,
DOI : 10.1073/pnas.76.9.4350
NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN, Cell, vol.128, issue.1, pp.129-168, 2007. ,
DOI : 10.1016/j.cell.2006.11.039
The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway., Genes & Development, vol.10, issue.10, pp.1219-1251, 1996. ,
DOI : 10.1101/gad.10.10.1219
Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases, Nature, vol.376, issue.6535, pp.88-91, 1995. ,
DOI : 10.1038/376088a0
Cationic lipids, lipoplexes and intracellular delivery of genes, Journal of Controlled Release, vol.116, issue.2, pp.255-64, 2006. ,
DOI : 10.1016/j.jconrel.2006.06.024
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression, Proceedings of the National Academy of Sciences, vol.94, issue.17, pp.5246-50, 1998. ,
DOI : 10.1073/pnas.94.17.9052
Restoration of Wild???Type p53 Function in Human Tumors: Strategies for Efficient Cancer Therapy, Adv Cancer Res, vol.97, pp.321-359, 2007. ,
DOI : 10.1016/S0065-230X(06)97014-6
Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle, J Cell Sci, vol.103, pp.1249-59, 1992. ,
Electric field mediated gene transfer, Biochemical and Biophysical Research Communications, vol.107, issue.2, pp.584-591, 1982. ,
DOI : 10.1016/0006-291X(82)91531-5
DNA-dependent protein kinase acts upstream of p53 in response to DNA damage, Nature, vol.11, issue.6694, pp.700-704, 1998. ,
DOI : 10.1128/MCB.11.1.12
KILLER/DR5 is a DNA damage???inducible p53???regulated death receptor gene, Nature Genetics, vol.54, issue.2, pp.141-144, 1997. ,
DOI : 10.1126/science.277.5327.818
Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase, Journal of Biological Chemistry, vol.283, issue.28, pp.21477-85, 2000. ,
DOI : 10.1083/jcb.138.4.845
Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF??B-dependent Pathway, Journal of Biological Chemistry, vol.282, issue.6, pp.3507-3526, 2007. ,
DOI : 10.1074/jbc.M610141200
The EGFR family and its ligands in human cancer, European Journal of Cancer, vol.37, issue.4, pp.3-8, 2001. ,
DOI : 10.1016/S0959-8049(01)00230-1
The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death, Cell Death & Differentiation, vol.199, issue.11, pp.1872-1881, 2007. ,
DOI : 10.1038/sj.cdd.4402204
Bax suppresses tumorigenesis and stimulates apoptosis in vivo, Nature, vol.385, issue.6617, pp.637-677, 1997. ,
DOI : 10.1038/385637a0
PUMA mediates the apoptotic response to p53 in colorectal cancer cells, Proceedings of the National Academy of Sciences, vol.275, issue.5302, pp.1931-1937, 2003. ,
DOI : 10.1126/science.275.5302.967
Two immunoglobulin G fragment C receptor polymorphisms associated with clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with single agent cetuximab, J Clin Oncol, vol.3028, 2006. ,
PPAR?? activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404, Cancer Biology & Therapy, vol.5, issue.8, pp.1008-1022, 2006. ,
DOI : 10.4161/cbt.5.8.2887